Relationship of anthracycline and cardiac dysfunction according to the type of malignancy
| Malignancy | Cardiac dysfunction | p Value | OR (95% CI) | |
|---|---|---|---|---|
| Within a month n (%) | Within a year n (%) | |||
| ALL (n=70) | 3 (4) | 12 (17) | 0.004 | 1.3 (1.0 to 1.8) |
| AML (n=12) | 5 (42) | 9 (75) | 0.091 | 2.3 (1.1 to 4.7) |
| Hodgkin lymphoma (n=12) | 3 (25) | 2 (17) | 0.045 | 0.1 (0.1 to 0.6) |
| Non-Hodgkin lymphoma (n=7) | 2 (28) | 2 (28) | 1.000 | 4.0 (0.1 to 136.9) |
ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia.